Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
text
Tags
tc
12
×
startups
health
events
medical research
ajay royan
alphabet
american biochemists
applied genetics
articles
asthma
athenahealth
balderton capital
battlefield
berkeley college of chemistry faculty
bessemer venture partners
beth seidenberg
bio
bioethics
biontech
biotech
biotechnology
brian armstrong
bright health
caspar health
castlight health
ceo
clinical trials
cloudflare
coinbase
crispr
crystallographers
disrupt berlin 2017
disrupt europe 2014
disrupt sf 2016
dropbox
eaze
ecommerce
emerging technologies
enzymes
What
disrupt
12
×
startup
medical
read
stage
early
industry
million
sf
startups
coming
companies
health
patients
raised
techcrunch
we’re
access
asthma
batch
battlefield
best
biotech
ceo
company
connected
diagnostics
disappoint
drugs
enterprise
entrepreneurs
excited
founder
group
introduce
introducing
medicine
molecular
participating
people
Language
unset
Current search:
disrupt
×
tc
×
@techcrunch.com
2 years ago
BioNTech founder Uğur Şahin and Mayfield’s Ursheet Parikh are coming to Disrupt
@techcrunch.com
4 years ago
After selling Auris for $3.4 billion to J&J, CEO Frederic Moll and lead investor Ajay Royan come to Disrupt
@techcrunch.com
4 years ago
Pax Labs CEO Bharat Vassan and serial founder Keith McCarty are coming to Disrupt SF
@techcrunch.com
5 years ago
Insurance startup Bright Health raises $200M at ~$950M valuation
@techcrunch.com
6 years ago
Caspar Health makes rehabilitative care more accessible by putting treatment plans in an app
@techcrunch.com
7 years ago
SCiO, the pocket-sized molecular analyzer, is making everyone angry
@techcrunch.com
7 years ago
Jennifer Doudna, inventor of gene editing technology CRISPR Cas9, is coming to Disrupt
@techcrunch.com
8 years ago
Cohero Health Aims To Improve Patient Care For The 26 Million American Asthma Sufferers
@techcrunch.com
8 years ago
M.D. Turned VC Beth Seidenberg To Talk Biotech Startups At Disrupt SF
@techcrunch.com
9 years ago
Amid ‘Right To Try’ Debate, myTomorrows Raises €4.5M To Give Patients Access To Development-Stage Drugs
@techcrunch.com
9 years ago
Introducing The 14 Companies Participating In Disrupt London: Startup Battlefield
@techcrunch.com
9 years ago
Introducing The Disrupt SF 2014 Startup Battlefield